Bladder cancer: Quality of life in patients with non-muscle-invasive bladder cancer

Nature Reviews Urology

Volumn 12, Issue 4, 2015, Pages 186-188

  Sanchez, Alejandro ^a   Wszolek, Matthew F ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURGERY; CHEMORADIOTHERAPY; COMORBIDITY; CYSTECTOMY; HUMAN; INTESTINE FUNCTION; MAINTENANCE THERAPY; NON MUSCLE INVASIVE BLADDER CANCER; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT FORM 36; SHORT SURVEY; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; BLADDER TUMOR; FEMALE; MALE; PATHOPHYSIOLOGY; PSYCHOLOGY;

FEMALE; HUMANS; MALE; URINARY BLADDER NEOPLASMS;

EID: 84927090068     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2015.12     Document Type: Short Survey

References (10)

1. Schmidt, S. et al. Quality of life in patients with non-muscle-invasive bladder cancer: one-year results of a multicentre prospective cohort study. Urol. Oncol. http://dx.doi.org/10.1016/j.urolonc.2014.09.012.
2. Fung, C. et al. Imp act of bladder cancer on health related quality of life in 1,476 older Americans: a cross-sectional study. J. Urol. 192, 690-695 (2014).
3. Gontero, P. et al. The impact of intravesical gemcitabin e and 1/3 dose Bacillus Calmette-Guerin instillation therapy on the quality of life in patients with nonmuscle invasive bladder cancer: results of a prospective, randomized, phase II trial. J. Urol. 190, 857-862 (2013).
4. Blazeby J. M.,et al Validation and reliability testing of the EORTC QLQ-NMIBC24 questionnaire module to assess patient-reported outcomes in non-muscle-invasive bladder cancer. Eur. Urol. 66 1148-1156 2014)
5. US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT00981656?term=RTOG+0926&rank=1 (2014).
6. Zietman, A. L. et al. Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors. J. Urol. 170, 1772-1776 (2003).
7. Efstathiou, J. A. et al. Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience. Eur. Urol. 61, 705-711 (2012).
8. Weiss, C. et al. Manag ement of superficial recurrences in an irradiated bladder after combined-modality organ-preserving therapy. Int. J. Radiat. Oncol. Biol. Phys. 70, 1502-1506 (2008).
9. Zietman, A. L. et al. Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder. Urology 58, 380-385 (2001).
10. Sapre, N., Anderson, P. & Foroudi, F. Management of local recurrences in the irradiated bladder: a systematic review. BJU Int. 110, S51-S57 (2012).